NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
AskQtyOrders

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

505.453 days ago
518.002 days ago
arrow

LOWER/UPPER CIRCUITS

407.80
611.60
arrow
Hindustan Foods Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral

Our researchers has found no immediate positive insights for this stock. We'll update this space as soon as we find something.

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : %
Net profit growth 5Y CAGR : 55.59%
Hindustan Foods Ltd Top mutual funds holding
arrow

About Hindustan Foods Limited (HFL)

Hindustan Foods Limited (HFL) is one of India’s largest and most diversified FMCG contract manufacturers, incorporated in 1984 and domiciled in India. The Company’s registered and principal office is located at Office No. 03, Level 2, Centrium, Phoenix Market City, Kurla, Mumbai – 400070.

HFL commenced operations in 1988 and is listed on both BSE and NSE. It operates a robust network of 28 state-of-the-art manufacturing facilities across India, providing end-to-end manufacturing and integrated backend services encompassing processing, packaging, warehousing, and logistics.

The Company’s core business lies in contract manufacturing for leading FMCG brands across home care, personal care, food and beverages, and job-working of shoes. Over time, HFL has diversified into footwear, ice cream, OTC healthcare, and allied categories, expanding its role as a strategic manufacturing partner for global and domestic clients.

The Company caters to both domestic and international markets and has resumed exports in OTC pharma to multiple regions, including the UAE, Australia, and Africa. As of March 31, 2025, HFL had five subsidiaries (including four wholly-owned subsidiaries and one subsidiary LLP).

Key milestones during FY 2024–25 include the 40th Annual Report, crossing Rs. 100 crore in Profit After Tax, and significant diversification and capacity expansion across product categories and geographies. HFL also maintains an extensive suite of international accreditations, including FSSC 22000, ISO 9001:2015, ISO 14001:2015, ISO 45001:2018, ISO 13485:2016, BRC GS (Consumer Products and GFSI), MHRA certification, and Sedex SMETA 4-pillar.

HFL Key Management

NameDesignation
Sameer R. KothariManaging Director
Ganesh T. ArgekarExecutive Director & Whole-Time Director
Mayank SamdaniChief Financial Officer & Group CFO
Bankim PurohitCompany Secretary & Legal Head

 

Latest Updates on Hindustan Foods Limited

  1. Category Expansion and Diversification
    HFL strengthened its focus on four key growth areas — Shoes, OTC Pharma, Ice Creams, and Beverages — supported by long-term take-or-pay contracts in select segments.
  • Achieved record beverage production volumes in FY 2024–25.

  • Introduced DOY packaging at the Mysuru plant.

  • Scaled up the OTC pharma vertical anchored at Baddi, resuming exports and securing new international approvals.

  1. Capacity Additions and Acquisitions
  • Rs. 15 crore investment approved to expand Mysuru beverage capacity by 30%.

  • Acquired a beverage unit in Odisha, strengthening manufacturing reach.

  • Established Ice Cream as a Strategic Business Unit (SBU) with in-house cone production commencing in April 2025.

  • Ongoing capex of over Rs. 600 crore across facilities, including Rs. 250 crore at Lucknow and a greenfield plant in North India scheduled for FY 2026–27.

  • The Nashik greenfield ice cream project began commercial production in May 2025.

  1. Footwear Scale-Up
  • Integrated a going concern in North India encompassing five specialised units, adding approximately 4,500 employees.

  • Expanded sports shoe manufacturing in Tamil Nadu and announced plans for a new footwear facility in Karnataka.

  • The footwear division is expected to contribute 15–20% of overall business revenue over the medium term.

  1. Capital and Governance Actions
  • Raised Rs. 295 crore through a preferential issue of warrants and their conversion by March 31, 2025, earmarked for greenfield and brownfield capex, inorganic opportunities, and general corporate purposes.

  • Introduced the HFL Employee Stock Option Scheme 2025 (HFL ESOS 2025); post year-end, 1,47,100 stock options were granted on July 28, 2025, to eligible employees across the Company and subsidiaries.

  1. Listings and Certifications
  • Equity shares continued to trade on BSE and NSE.

  • 97.84% of shares were in dematerialised form as of March 31, 2025.

  • The Company reaffirmed its commitment to global quality, safety, and sustainability standards through ongoing audits and renewals of international certifications.

Products and Services of Hindustan Foods Limited

HFL’s portfolio spans multiple FMCG verticals, including:

  • Home and personal care: detergents, fabric conditioners, and beauty products.

  • Food and beverages: hot and cold beverages, soups, spice mixes, sauces, jams, cookies, and nutrition bars.

  • Pet hygiene and food.

  • Footwear: leather and sports shoes, and foot care accessories.

  • OTC healthcare and protein-based nutrition drinks.

  • Ice cream and frozen desserts.

  • Pest control, spices, and seasonings.

The Company operates through three flexible manufacturing models:

  • Dedicated Manufacturing Units (DMUs) for long-term clients,

  • Shared Production Units (SPUs) for efficient multi-brand utilisation, and

Turnkey Private Label Solutions offering product design-to-delivery support with integrated logistics and supply-chain management.

personal

Grow your wealth with more research recommendations

+91

Frequently Asked Questions

HFL is a contract manufacturer for leading FMCG brands across home care, personal care, food, beverages, footwear, and OTC healthcare, providing end-to-end manufacturing and integrated backend services across India.

HFL operates 28 advanced manufacturing facilities across India and has five subsidiaries, including four wholly-owned subsidiaries and one subsidiary LLP.

he Company’s equity shares are listed on BSE and NSE. HFL serves both Indian and international markets, with exports in OTC pharma to regions including the UAE, Australia, and Africa.